BN Business News
Add your company to Business Communicator →

Regulation & law · 18/12/2014

NIH Seeks Exclusive License for Multivalent Vaccines Against Rabies and Filoviruses

The National Institutes of Health is seeking an exclusive license to practice multivalent vaccines for rabies virus and filoviruses, including Ebola and Marburg, from Exxell BIO, Inc., a Minnesota-based company.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights